These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 18684368

  • 1. Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy.
    Romero-Puche A, Marín F, González-Carrillo J, García-Honrubia A, Climent V, Feliu E, Ruiz-Espejo F, Payá E, Gimeno-Blanes JR, de la Morena G, Valdés-Chavarri M.
    Rev Esp Cardiol; 2008 Aug; 61(8):853-60. PubMed ID: 18684368
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V.
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [Abstract] [Full Text] [Related]

  • 3. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M.
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance].
    Pujadas S, Carreras F, Arrastio X, Leta R, Vila M, Subirana MT, Bayés-Genís A, Pons-Lladó G.
    Rev Esp Cardiol; 2007 Jan; 60(1):10-4. PubMed ID: 17288950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
    Oka K, Tsujino T, Nakao S, Lee-Kawabata M, Ezumi A, Masai M, Ohyanagi M, Masuyama T.
    J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.
    Aquaro GD, Masci P, Formisano F, Barison A, Strata E, Pingitore A, Positano V, Spirito P, Lombardi M.
    Am J Cardiol; 2010 Feb 01; 105(3):392-7. PubMed ID: 20102955
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy.
    Moreno V, Hernández-Romero D, Vilchez JA, García-Honrubia A, Cambronero F, Casas T, González J, Martínez P, Climent V, de la Morena G, Valdés M, Marín F.
    J Card Fail; 2010 Dec 01; 16(12):950-6. PubMed ID: 21111984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.